Clinical Progress of Covid 19 disease in Pregnancy
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/06/034117
- Lead Sponsor
- Kaliga Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All female patient admitted to Odisha KIMS Covid Hospital from March 2020 to May 2021
Exclusion Criteria
Any preexisting medical disorder like diabetes, hypertension, heart disease or respiratory disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What immunomodulatory pathways are linked to SARS-CoV-2 progression in pregnancy in CTRI/2021/06/034117?
How does CTRI/2021/06/034117 compare SARS-CoV-2 outcomes in pregnant versus non-pregnant patients?
Which cytokine profiles predict severe SARS-CoV-2 outcomes in pregnant women in CTRI/2021/06/034117?
What maternal and neonatal adverse events are reported in CTRI/2021/06/034117's SARS-CoV-2 pregnancy study?
How do antiviral therapies like remdesivir or corticosteroids impact SARS-CoV-2 outcomes in pregnancy in CTRI/2021/06/034117?